Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street On Friday » 16:24
05/26/23
05/26
16:24
05/26/23
16:24
WBA

Walgreens Boots Alliance

$30.00 /

+0.04 (+0.13%)

, JPM

JPMorgan

$136.94 /

+1.27 (+0.94%)

, FRCB

First Republic Bank

/

+

, TEVA

Teva

$7.44 /

+0.11 (+1.50%)

, NEWR

New Relic

$72.32 /

-5.905 (-7.55%)

, DB

Deutsche Bank

$10.46 /

+0.02 (+0.19%)

, F

Ford

$12.10 /

+0.715 (+6.28%)

, COST

Costco

$507.32 /

+20.265 (+4.16%)

, TSLA

Tesla

$193.14 /

+8.715 (+4.73%)

, WDAY

Workday

$216.03 /

+19.81 (+10.10%)

, GPS

Gap

$8.34 /

+0.92 (+12.40%)

, COP

ConocoPhillips

$101.83 /

+0.15 (+0.15%)

, TTE

TotalEnergies

$59.69 /

+0.355 (+0.60%)

, GH

Guardant Health

$28.10 /

+0.2 (+0.72%)

, MDB

MongoDB

$283.32 /

-1.915 (-0.67%)

, PARA

Paramount

$14.91 /

+0.825 (+5.86%)

, PARAA

Paramount

$17.44 /

+1.195 (+7.36%)

, EFTR

eFfector Therapeutics

/

+

, LLAP

Terran Orbital

$1.18 /

-0.06 (-4.84%)

, COHR

Coherent

$36.97 /

+4.57 (+14.10%)

, PDD

PDD Holdings

$71.43 /

+11.44 (+19.07%)

, GERN

Geron

$3.27 /

+0.12 (+3.82%)

, TLRY

Tilray

$1.86 /

-0.495 (-21.02%)

, DLO

DLocal

$11.41 /

-2.415 (-17.47%)

, MRVL

Marvell

$65.51 /

+16.055 (+32.47%)

, ULTA

Ulta Beauty

$420.13 /

-65.52 (-13.49%)

, ADSK

Autodesk

$198.82 /

+1.25 (+0.63%)

, HIBB

Hibbett

$39.20 /

-4.9 (-11.11%)

, BIG

Big Lots

$6.27 /

-0.945 (-13.10%)

Get caught up quickly on…

ShowHide Related Items >><<
WDAY Workday
$216.03 /

+19.81 (+10.10%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TLRY Tilray
$1.86 /

-0.495 (-21.02%)

TEVA Teva
$7.44 /

+0.11 (+1.50%)

PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

PARAA Paramount
$17.44 /

+1.195 (+7.36%)

PARA Paramount
$14.91 /

+0.825 (+5.86%)

NEWR New Relic
$72.32 /

-5.905 (-7.55%)

MRVL Marvell
$65.51 /

+16.055 (+32.47%)

MDB MongoDB
$283.32 /

-1.915 (-0.67%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

GPS Gap
$8.34 /

+0.92 (+12.40%)

GH Guardant Health
$28.10 /

+0.2 (+0.72%)

GERN Geron
$3.27 /

+0.12 (+3.82%)

FRCB First Republic Bank
/

+

F Ford
$12.10 /

+0.715 (+6.28%)

EFTR eFfector Therapeutics
/

+

DLO DLocal
$11.41 /

-2.415 (-17.47%)

DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

COST Costco
$507.32 /

+20.265 (+4.16%)

COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

COHR Coherent
$36.97 /

+4.57 (+14.10%)

BIG Big Lots
$6.27 /

-0.945 (-13.10%)

ADSK Autodesk
$198.82 /

+1.25 (+0.63%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

03/30/23 Deutsche Bank
Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
03/29/23 UBS
Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
03/29/23 Truist
Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
03/26/23 Barclays
Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

05/23/23 Morgan Stanley
JPMorgan price target raised to $160 from $157 at Morgan Stanley
05/15/23 Jefferies
JPMorgan price target lowered to $149 from $152 at Jefferies
05/12/23 Citi
State Street, BNY Mellon hurt most from FDIC proposal, says Citi
05/12/23 Evercore ISI
JPMorgan price target lowered to $151 from $155 at Evercore ISI
FRCB First Republic Bank
/

+

TEVA Teva
$7.44 /

+0.11 (+1.50%)

05/25/23 Morgan Stanley
Teva initiated with an Equal Weight at Morgan Stanley
05/18/23 Evercore ISI
Teva upgraded to Outperform at Evercore ISI on TL1A and olanzapine potential
05/18/23 Evercore ISI
Teva upgraded to Outperform from In Line at Evercore ISI
05/11/23 BofA
Teva pullback a 'particularly attractive opportunity,' says BofA
NEWR New Relic
$72.32 /

-5.905 (-7.55%)

05/26/23 DA Davidson
DA Davidson positive on New Relic ability to accelerate growth
05/26/23 RBC Capital
RBC upgrades New Relic on accelerating growth visibility
05/26/23 RBC Capital
New Relic upgraded to Outperform from Sector Perform at RBC Capital
05/24/23 Truist
New Relic price target raised to $77 from $65 at Truist
DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

05/04/23 Citi
Deutsche Bank upgraded to Buy from Neutral at Citi
04/24/23 Barclays
Deutsche Bank price target lowered to EUR 12 from EUR 12.50 at Barclays
02/10/23 BofA
Deutsche Bank downgraded to Underperform from Neutral at BofA
02/08/23 UBS
Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS
F Ford
$12.10 /

+0.715 (+6.28%)

05/25/23 Daiwa
Ford upgraded to Neutral from Underperform at Daiwa
05/17/23 Deutsche Bank
Deutsche says Ford event may clear way for investor caution
05/15/23 Citi
Ford price target raised to $12.80 from $12.50 at Citi
05/03/23 Benchmark
Ford price target raised to $20 from $19 at Benchmark
COST Costco
$507.32 /

+20.265 (+4.16%)

05/26/23 Loop Capital
Costco price target lowered to $545 from $550 at Loop Capital
05/26/23 Roth MKM
Costco price target lowered to $482 from $492 at Roth MKM
05/26/23 UBS
Costco price target lowered to $560 from $575 at UBS
05/04/23 Truist
Costco price target lowered to $568 from $571 at Truist
TSLA Tesla
$193.14 /

+8.715 (+4.73%)

05/23/23 Oppenheimer
Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer
05/18/23 Wedbush
Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars
05/17/23 Wedbush
Potential advertising campaign 'a major positive' for Tesla, says Wedbush
05/17/23 Bernstein
2024 could be even more challenging for Tesla, says Bernstein
WDAY Workday
$216.03 /

+19.81 (+10.10%)

05/26/23 Loop Capital
Workday price target raised to $210 from $180 at Loop Capital
05/26/23 BMO Capital
Workday price target raised to $240 from $205 at BMO Capital
05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/26/23 Canaccord
Workday price target raised to $240 from $210 at Canaccord
GPS Gap
$8.34 /

+0.92 (+12.40%)

05/26/23 BofA
Gap price target lowered to $8.50 from $9.50 at BofA
05/26/23 Baird
Gap price target lowered to $10 from $12 at Baird
05/19/23 Citi
Gap upgraded to Neutral from Sell at Citi
05/09/23 Jefferies
Gap price target lowered to $9 from $11 at Jefferies
COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

05/19/23 Mizuho
ConocoPhillips price target lowered to $126 from $128 at Mizuho
05/18/23 Piper Sandler
ConocoPhillips price target raised to $149 from $140 at Piper Sandler
05/15/23 Morgan Stanley
ConocoPhillips price target raised to $124 from $122 at Morgan Stanley
05/01/23 Goldman Sachs
Exxon Mobil downgraded to Neutral from Buy at Goldman Sachs
TTE TotalEnergies
$59.69 /

+0.355 (+0.60%)

05/19/23 Deutsche Bank
TotalEnergies price target raised to EUR 59.80 from EUR 56.20 at Deutsche Bank
05/18/23 Piper Sandler
TotalEnergies price target lowered to $68 from $69 at Piper Sandler
04/19/23 JPMorgan
TotalEnergies price target lowered to EUR 69 from EUR 73 at JPMorgan
04/11/23 Redburn
TotalEnergies upgraded to Neutral from Sell at Redburn
GH Guardant Health
$28.10 /

+0.2 (+0.72%)

05/26/23 Citi
Citi upgrades Guardant Health to Buy with key overhangs removed
05/26/23 Citi
Guardant Health upgraded to Buy from Neutral at Citi
05/15/23 Piper Sandler
Guardant Health price target lowered to $30 from $35 at Piper Sandler
05/10/23 Craig-Hallum
Craig-Hallum upgrades Exact Sciences to Buy, raises price target to $85
MDB MongoDB
$283.32 /

-1.915 (-0.67%)

05/26/23 Guggenheim
MongoDB downgraded to Sell at Guggenheim on growth and valuation concerns
05/25/23 Guggenheim
MongoDB downgraded to Sell from Neutral at Guggenheim
05/15/23 Barclays
MongoDB price target raised to $280 from $257 at Barclays
PARA Paramount
$14.91 /

+0.825 (+5.86%)

05/26/23 Loop Capital
Loop Capital upgrades Paramount to Hold as controlling shareholder raises funds
05/26/23 Loop Capital
Paramount upgraded to Hold from Sell at Loop Capital
05/24/23 Deutsche Bank
Paramount price target lowered to $25 from $28 at Deutsche Bank
PARAA Paramount
$17.44 /

+1.195 (+7.36%)

EFTR eFfector Therapeutics
/

+

05/26/23 Mizuho
eFfector Therapeutics posted positive breast cancer data, says Mizuho
05/26/23 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

05/26/23 BofA
Terran Orbital double downgraded to Underperform at BofA
05/26/23 BofA
Terran Orbital downgraded to Underperform from Buy at BofA
05/16/23 B. Riley
Terran Orbital price target lowered to $7.50 from $10 at B. Riley
05/16/23 Stifel
Terran Orbital price target lowered to $7 from $8 at Stifel
COHR Coherent
$36.97 /

+4.57 (+14.10%)

05/12/23 Northland
Coherent price target lowered to $38 from $52.50 at Northland
05/11/23 Deutsche Bank
Coherent price target lowered to $40 from $45 at Deutsche Bank
05/11/23 B. Riley
Coherent price target lowered to $47 from $67 at B. Riley
05/11/23 Craig-Hallum
Coherent price target lowered to $38 from $57 at Craig-Hallum
PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

05/02/23 Citi
PDD Holdings price target lowered to $100 from $115 at Citi
04/24/23 Goldman Sachs
PDD Holdings cut to Neutral at Goldman Sachs amid ad growth moderation
04/24/23 Goldman Sachs
PDD Holdings downgraded to Neutral from Buy at Goldman Sachs
04/13/23 UBS
JD.com downgraded to Neutral at UBS on competitive headwinds
GERN Geron
$3.27 /

+0.12 (+3.82%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
TLRY Tilray
$1.86 /

-0.495 (-21.02%)

04/12/23 Roth MKM
Tilray price target lowered to $2.50 from $3.00 at Roth MKM
04/11/23 TD Cowen
Tilray price target lowered to $5 from $9 at TD Cowen
01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
DLO DLocal
$11.41 /

-2.415 (-17.47%)

05/19/23 BofA
DLocal price target raised to $16 from $15 at BofA
05/11/23 Barclays
DLocal initiated with an Underweight at Barclays
04/13/23 HSBC
DLocal downgraded to Hold at HSBC on near-term margin pressure
04/13/23 HSBC
DLocal downgraded to Hold from Buy at HSBC
MRVL Marvell
$65.51 /

+16.055 (+32.47%)

05/26/23 Needham
Marvell price target raised to $65 from $50 at Needham
05/26/23 Evercore ISI
Marvell price target raised to $70 from $60 at Evercore ISI
05/26/23 Raymond James
Marvell price target raised to $64 from $50 at Raymond James
05/26/23 Craig-Hallum
Marvell price target raised to $67 from $56 at Craig-Hallum
ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

05/26/23 Loop Capital
Ulta Beauty price target lowered to $490 from $535 at Loop Capital
05/26/23 Raymond James
Ulta Beauty price target lowered to $600 from $615 at Raymond James
05/26/23 DA Davidson
Ulta Beauty price target lowered to $540 from $620 at DA Davidson
05/26/23 Oppenheimer
Ulta Beauty price target lowered to $540 from $575 at Oppenheimer
ADSK Autodesk
$198.82 /

+1.25 (+0.63%)

05/24/23 BMO Capital
Autodesk initiated with a Market Perform at BMO Capital
05/23/23 Citi
Autodesk price target lowered to $241 from $265 at Citi
05/19/23 Baird
Autodesk price target lowered to $230 from $247 at Baird
05/19/23 Stifel
Autodesk price target lowered to $240 from $245 at Stifel
HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

05/26/23 Baird
Hibbett price target lowered to $50 from $80 at Baird
05/26/23 BofA
Hibbett downgraded to Underperform from Buy at BofA
05/26/23 Williams Trading
Hibbett cut to Sell at Williams Trading after 'far worse' than expected outlook
05/26/23 Williams Trading
Hibbett downgraded to Sell from Hold at Williams Trading
BIG Big Lots
$6.27 /

-0.945 (-13.10%)

04/21/23 Piper Sandler
Big Lots downgraded to Underweight from Neutral at Piper Sandler
01/05/23 Deutsche Bank
Big Lots price target lowered to $9 from $10 at Deutsche Bank
12/19/22 Credit Suisse
Big Lots initiated with an Underperform at Credit Suisse
12/06/22 Deutsche Bank
Big Lots price target lowered to $10 from $13 at Deutsche Bank
WDAY Workday
$216.03 /

+19.81 (+10.10%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

TTE TotalEnergies
$59.69 /

+0.355 (+0.60%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TLRY Tilray
$1.86 /

-0.495 (-21.02%)

TEVA Teva
$7.44 /

+0.11 (+1.50%)

PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

PARA Paramount
$14.91 /

+0.825 (+5.86%)

NEWR New Relic
$72.32 /

-5.905 (-7.55%)

MRVL Marvell
$65.51 /

+16.055 (+32.47%)

MDB MongoDB
$283.32 /

-1.915 (-0.67%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

GPS Gap
$8.34 /

+0.92 (+12.40%)

GH Guardant Health
$28.10 /

+0.2 (+0.72%)

GERN Geron
$3.27 /

+0.12 (+3.82%)

F Ford
$12.10 /

+0.715 (+6.28%)

EFTR eFfector Therapeutics
/

+

DLO DLocal
$11.41 /

-2.415 (-17.47%)

DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

COST Costco
$507.32 /

+20.265 (+4.16%)

COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

COHR Coherent
$36.97 /

+4.57 (+14.10%)

BIG Big Lots
$6.27 /

-0.945 (-13.10%)

ADSK Autodesk
$198.82 /

+1.25 (+0.63%)

  • 23
    May
  • 06
    Jan
WDAY Workday
$216.03 /

+19.81 (+10.10%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

TTE TotalEnergies
$59.69 /

+0.355 (+0.60%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TLRY Tilray
$1.86 /

-0.495 (-21.02%)

TEVA Teva
$7.44 /

+0.11 (+1.50%)

PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

PARAA Paramount
$17.44 /

+1.195 (+7.36%)

PARA Paramount
$14.91 /

+0.825 (+5.86%)

NEWR New Relic
$72.32 /

-5.905 (-7.55%)

MRVL Marvell
$65.51 /

+16.055 (+32.47%)

JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

GPS Gap
$8.34 /

+0.92 (+12.40%)

FRCB First Republic Bank
/

+

F Ford
$12.10 /

+0.715 (+6.28%)

DLO DLocal
$11.41 /

-2.415 (-17.47%)

DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

COST Costco
$507.32 /

+20.265 (+4.16%)

COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

WDAY Workday
$216.03 /

+19.81 (+10.10%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

TTE TotalEnergies
$59.69 /

+0.355 (+0.60%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TLRY Tilray
$1.86 /

-0.495 (-21.02%)

TEVA Teva
$7.44 /

+0.11 (+1.50%)

PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

PARAA Paramount
$17.44 /

+1.195 (+7.36%)

PARA Paramount
$14.91 /

+0.825 (+5.86%)

NEWR New Relic
$72.32 /

-5.905 (-7.55%)

MRVL Marvell
$65.51 /

+16.055 (+32.47%)

MDB MongoDB
$283.32 /

-1.915 (-0.67%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

GPS Gap
$8.34 /

+0.92 (+12.40%)

GH Guardant Health
$28.10 /

+0.2 (+0.72%)

GERN Geron
$3.27 /

+0.12 (+3.82%)

F Ford
$12.10 /

+0.715 (+6.28%)

DLO DLocal
$11.41 /

-2.415 (-17.47%)

DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

COST Costco
$507.32 /

+20.265 (+4.16%)

COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

COHR Coherent
$36.97 /

+4.57 (+14.10%)

BIG Big Lots
$6.27 /

-0.945 (-13.10%)

ADSK Autodesk
$198.82 /

+1.25 (+0.63%)

WDAY Workday
$216.03 /

+19.81 (+10.10%)

WBA Walgreens Boots Alliance
$30.00 /

+0.04 (+0.13%)

ULTA Ulta Beauty
$420.13 /

-65.52 (-13.49%)

TTE TotalEnergies
$59.69 /

+0.355 (+0.60%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TLRY Tilray
$1.86 /

-0.495 (-21.02%)

TEVA Teva
$7.44 /

+0.11 (+1.50%)

PDD PDD Holdings
$71.43 /

+11.44 (+19.07%)

PARA Paramount
$14.91 /

+0.825 (+5.86%)

NEWR New Relic
$72.32 /

-5.905 (-7.55%)

MRVL Marvell
$65.51 /

+16.055 (+32.47%)

MDB MongoDB
$283.32 /

-1.915 (-0.67%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.94 /

+1.27 (+0.94%)

GPS Gap
$8.34 /

+0.92 (+12.40%)

GH Guardant Health
$28.10 /

+0.2 (+0.72%)

F Ford
$12.10 /

+0.715 (+6.28%)

DLO DLocal
$11.41 /

-2.415 (-17.47%)

DB Deutsche Bank
$10.46 /

+0.02 (+0.19%)

COST Costco
$507.32 /

+20.265 (+4.16%)

COP ConocoPhillips
$101.83 /

+0.15 (+0.15%)

BIG Big Lots
$6.27 /

-0.945 (-13.10%)

ADSK Autodesk
$198.82 /

+1.25 (+0.63%)

On The Fly
What You Missed On Wall Street This Morning » 12:01
05/26/23
05/26
12:01
05/26/23
12:01
F

Ford

$12.07 /

+0.69 (+6.06%)

, TSLA

Tesla

$192.63 /

+8.21 (+4.45%)

, COST

Costco

$501.79 /

+14.74 (+3.03%)

, WDAY

Workday

$217.97 /

+21.75 (+11.08%)

, GPS

Gap

$8.21 /

+0.79 (+10.65%)

, MRVL

Marvell

$62.70 /

+13.25 (+26.79%)

, GH

Guardant Health

$28.25 /

+0.35 (+1.25%)

, MDB

MongoDB

$289.57 /

+4.335 (+1.52%)

, PARA

Paramount

$14.89 /

+0.805 (+5.72%)

, PARAA

Paramount

$17.34 /

+1.1 (+6.77%)

, EFTR

eFfector Therapeutics

/

+

, LLAP

Terran Orbital

$1.18 /

-0.06 (-4.84%)

, WBA

Walgreens Boots Alliance

$29.79 /

-0.17 (-0.57%)

, JPM

JPMorgan

$136.91 /

+1.24 (+0.91%)

, FRCB

First Republic Bank

/

+

, TEVA

Teva

$7.44 /

+0.105 (+1.43%)

, MU

Micron

$73.83 /

+4.24 (+6.09%)

, NVDA

Nvidia

$386.53 /

+7.01 (+1.85%)

, COHR

Coherent

$36.59 /

+4.19 (+12.93%)

, PDD

PDD Holdings

$70.51 /

+10.52 (+17.54%)

, GERN

Geron

$3.45 /

+0.305 (+9.70%)

, TLRY

Tilray

$1.87 /

-0.49 (-20.81%)

, DLO

DLocal

$10.74 /

-3.085 (-22.31%)

, ULTA

Ulta Beauty

$425.15 /

-60.5 (-12.46%)

, ADSK

Autodesk

$196.48 /

-1.09 (-0.55%)

, HIBB

Hibbett

$39.77 /

-4.33 (-9.82%)

, BKE

The Buckle

$31.81 /

+0.55 (+1.76%)

, BIG

Big Lots

$6.11 /

-1.105 (-15.32%)

Get caught up quickly on…

ShowHide Related Items >><<
WDAY Workday
$217.97 /

+21.75 (+11.08%)

WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

TSLA Tesla
$192.63 /

+8.21 (+4.45%)

TLRY Tilray
$1.87 /

-0.49 (-20.81%)

TEVA Teva
$7.44 /

+0.105 (+1.43%)

PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

PARAA Paramount
$17.34 /

+1.1 (+6.77%)

PARA Paramount
$14.89 /

+0.805 (+5.72%)

NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

MU Micron
$73.83 /

+4.24 (+6.09%)

MRVL Marvell
$62.70 /

+13.25 (+26.79%)

MDB MongoDB
$289.57 /

+4.335 (+1.52%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

HIBB Hibbett
$39.77 /

-4.33 (-9.82%)

GPS Gap
$8.21 /

+0.79 (+10.65%)

GH Guardant Health
$28.25 /

+0.35 (+1.25%)

GERN Geron
$3.45 /

+0.305 (+9.70%)

FRCB First Republic Bank
/

+

F Ford
$12.07 /

+0.69 (+6.06%)

EFTR eFfector Therapeutics
/

+

DLO DLocal
$10.74 /

-3.085 (-22.31%)

COST Costco
$501.79 /

+14.74 (+3.03%)

COHR Coherent
$36.59 /

+4.19 (+12.93%)

BKE The Buckle
$31.81 /

+0.55 (+1.76%)

BIG Big Lots
$6.11 /

-1.105 (-15.32%)

ADSK Autodesk
$196.48 /

-1.09 (-0.55%)

F Ford
$12.07 /

+0.69 (+6.06%)

05/25/23 Daiwa
Ford upgraded to Neutral from Underperform at Daiwa
05/17/23 Deutsche Bank
Deutsche says Ford event may clear way for investor caution
05/15/23 Citi
Ford price target raised to $12.80 from $12.50 at Citi
05/03/23 Benchmark
Ford price target raised to $20 from $19 at Benchmark
TSLA Tesla
$192.63 /

+8.21 (+4.45%)

05/23/23 Oppenheimer
Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer
05/18/23 Wedbush
Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars
05/17/23 Wedbush
Potential advertising campaign 'a major positive' for Tesla, says Wedbush
05/17/23 Bernstein
2024 could be even more challenging for Tesla, says Bernstein
COST Costco
$501.79 /

+14.74 (+3.03%)

05/26/23 Loop Capital
Costco price target lowered to $545 from $550 at Loop Capital
05/26/23 Roth MKM
Costco price target lowered to $482 from $492 at Roth MKM
05/26/23 UBS
Costco price target lowered to $560 from $575 at UBS
05/04/23 Truist
Costco price target lowered to $568 from $571 at Truist
WDAY Workday
$217.97 /

+21.75 (+11.08%)

05/26/23 Loop Capital
Workday price target raised to $210 from $180 at Loop Capital
05/26/23 BMO Capital
Workday price target raised to $240 from $205 at BMO Capital
05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/26/23 Canaccord
Workday price target raised to $240 from $210 at Canaccord
GPS Gap
$8.21 /

+0.79 (+10.65%)

05/26/23 BofA
Gap price target lowered to $8.50 from $9.50 at BofA
05/26/23 Baird
Gap price target lowered to $10 from $12 at Baird
05/19/23 Citi
Gap upgraded to Neutral from Sell at Citi
05/09/23 Jefferies
Gap price target lowered to $9 from $11 at Jefferies
MRVL Marvell
$62.70 /

+13.25 (+26.79%)

05/26/23 Needham
Marvell price target raised to $65 from $50 at Needham
05/26/23 Evercore ISI
Marvell price target raised to $70 from $60 at Evercore ISI
05/26/23 Raymond James
Marvell price target raised to $64 from $50 at Raymond James
05/26/23 Craig-Hallum
Marvell price target raised to $67 from $56 at Craig-Hallum
GH Guardant Health
$28.25 /

+0.35 (+1.25%)

05/26/23 Citi
Citi upgrades Guardant Health to Buy with key overhangs removed
05/26/23 Citi
Guardant Health upgraded to Buy from Neutral at Citi
05/15/23 Piper Sandler
Guardant Health price target lowered to $30 from $35 at Piper Sandler
05/10/23 Craig-Hallum
Craig-Hallum upgrades Exact Sciences to Buy, raises price target to $85
MDB MongoDB
$289.57 /

+4.335 (+1.52%)

05/26/23 Guggenheim
MongoDB downgraded to Sell at Guggenheim on growth and valuation concerns
05/25/23 Guggenheim
MongoDB downgraded to Sell from Neutral at Guggenheim
05/15/23 Barclays
MongoDB price target raised to $280 from $257 at Barclays
PARA Paramount
$14.89 /

+0.805 (+5.72%)

05/26/23 Loop Capital
Loop Capital upgrades Paramount to Hold as controlling shareholder raises funds
05/26/23 Loop Capital
Paramount upgraded to Hold from Sell at Loop Capital
05/24/23 Deutsche Bank
Paramount price target lowered to $25 from $28 at Deutsche Bank
PARAA Paramount
$17.34 /

+1.1 (+6.77%)

EFTR eFfector Therapeutics
/

+

05/26/23 Mizuho
eFfector Therapeutics posted positive breast cancer data, says Mizuho
05/26/23 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

05/26/23 BofA
Terran Orbital double downgraded to Underperform at BofA
05/26/23 BofA
Terran Orbital downgraded to Underperform from Buy at BofA
05/16/23 B. Riley
Terran Orbital price target lowered to $7.50 from $10 at B. Riley
05/16/23 Stifel
Terran Orbital price target lowered to $7 from $8 at Stifel
WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

03/30/23 Deutsche Bank
Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
03/29/23 UBS
Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
03/29/23 Truist
Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
03/26/23 Barclays
Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

05/23/23 Morgan Stanley
JPMorgan price target raised to $160 from $157 at Morgan Stanley
05/15/23 Jefferies
JPMorgan price target lowered to $149 from $152 at Jefferies
05/12/23 Citi
State Street, BNY Mellon hurt most from FDIC proposal, says Citi
05/12/23 Evercore ISI
JPMorgan price target lowered to $151 from $155 at Evercore ISI
FRCB First Republic Bank
/

+

TEVA Teva
$7.44 /

+0.105 (+1.43%)

05/25/23 Morgan Stanley
Teva initiated with an Equal Weight at Morgan Stanley
05/18/23 Evercore ISI
Teva upgraded to Outperform at Evercore ISI on TL1A and olanzapine potential
05/18/23 Evercore ISI
Teva upgraded to Outperform from In Line at Evercore ISI
05/11/23 BofA
Teva pullback a 'particularly attractive opportunity,' says BofA
MU Micron
$73.83 /

+4.24 (+6.09%)

05/26/23 BMO Capital
Micron price target raised to $80 from $67 at BMO Capital
05/23/23 Mizuho
Micron should be bought on China ban selloff, says Mizuho
05/22/23 Deutsche Bank
Full impact of China restrictions on Micron 'unclear,' says Deutsche Bank
05/22/23 Raymond James
Micron impact from China CAC decision to be 'modest,' says Raymond James
NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

05/26/23 TD Cowen
Marvell price target raised to $65 from $50 at TD Cowen
05/25/23 Morgan Stanley
Nvidia price target raised to $450 from $304 at Morgan Stanley
05/25/23 Craig-Hallum
Craig-Hallum upgrades Nvidia to Buy, raises price target to $500 from $190
05/25/23 Deutsche Bank
Nvidia price target raised to $390 from $220 at Deutsche Bank
COHR Coherent
$36.59 /

+4.19 (+12.93%)

05/12/23 Northland
Coherent price target lowered to $38 from $52.50 at Northland
05/11/23 Deutsche Bank
Coherent price target lowered to $40 from $45 at Deutsche Bank
05/11/23 B. Riley
Coherent price target lowered to $47 from $67 at B. Riley
05/11/23 Craig-Hallum
Coherent price target lowered to $38 from $57 at Craig-Hallum
PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

05/02/23 Citi
PDD Holdings price target lowered to $100 from $115 at Citi
04/24/23 Goldman Sachs
PDD Holdings cut to Neutral at Goldman Sachs amid ad growth moderation
04/24/23 Goldman Sachs
PDD Holdings downgraded to Neutral from Buy at Goldman Sachs
04/13/23 UBS
JD.com downgraded to Neutral at UBS on competitive headwinds
GERN Geron
$3.45 /

+0.305 (+9.70%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
TLRY Tilray
$1.87 /

-0.49 (-20.81%)

04/12/23 Roth MKM
Tilray price target lowered to $2.50 from $3.00 at Roth MKM
04/11/23 TD Cowen
Tilray price target lowered to $5 from $9 at TD Cowen
01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
DLO DLocal
$10.74 /

-3.085 (-22.31%)

05/19/23 BofA
DLocal price target raised to $16 from $15 at BofA
05/11/23 Barclays
DLocal initiated with an Underweight at Barclays
04/13/23 HSBC
DLocal downgraded to Hold at HSBC on near-term margin pressure
04/13/23 HSBC
DLocal downgraded to Hold from Buy at HSBC
ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

05/26/23 Loop Capital
Ulta Beauty price target lowered to $490 from $535 at Loop Capital
05/26/23 Raymond James
Ulta Beauty price target lowered to $600 from $615 at Raymond James
05/26/23 DA Davidson
Ulta Beauty price target lowered to $540 from $620 at DA Davidson
05/26/23 Oppenheimer
Ulta Beauty price target lowered to $540 from $575 at Oppenheimer
ADSK Autodesk
$196.48 /

-1.09 (-0.55%)

05/24/23 BMO Capital
Autodesk initiated with a Market Perform at BMO Capital
05/23/23 Citi
Autodesk price target lowered to $241 from $265 at Citi
05/19/23 Baird
Autodesk price target lowered to $230 from $247 at Baird
05/19/23 Stifel
Autodesk price target lowered to $240 from $245 at Stifel
HIBB Hibbett
$39.77 /

-4.33 (-9.82%)

05/26/23 Williams Trading
Hibbett cut to Sell at Williams Trading after 'far worse' than expected outlook
05/26/23 Williams Trading
Hibbett downgraded to Sell from Hold at Williams Trading
05/21/23 Williams Trading
Hibbett downgraded to Hold from Buy at Williams Trading
03/14/23 Jefferies
Hibbett initiated with a Hold at Jefferies
BKE The Buckle
$31.81 /

+0.55 (+1.76%)

04/10/23 UBS
The Buckle initiated with a Neutral at UBS
BIG Big Lots
$6.11 /

-1.105 (-15.32%)

04/21/23 Piper Sandler
Big Lots downgraded to Underweight from Neutral at Piper Sandler
01/05/23 Deutsche Bank
Big Lots price target lowered to $9 from $10 at Deutsche Bank
12/19/22 Credit Suisse
Big Lots initiated with an Underperform at Credit Suisse
12/06/22 Deutsche Bank
Big Lots price target lowered to $10 from $13 at Deutsche Bank
WDAY Workday
$217.97 /

+21.75 (+11.08%)

WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

TSLA Tesla
$192.63 /

+8.21 (+4.45%)

TLRY Tilray
$1.87 /

-0.49 (-20.81%)

TEVA Teva
$7.44 /

+0.105 (+1.43%)

PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

PARA Paramount
$14.89 /

+0.805 (+5.72%)

NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

MU Micron
$73.83 /

+4.24 (+6.09%)

MRVL Marvell
$62.70 /

+13.25 (+26.79%)

MDB MongoDB
$289.57 /

+4.335 (+1.52%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

HIBB Hibbett
$39.77 /

-4.33 (-9.82%)

GPS Gap
$8.21 /

+0.79 (+10.65%)

GH Guardant Health
$28.25 /

+0.35 (+1.25%)

GERN Geron
$3.45 /

+0.305 (+9.70%)

F Ford
$12.07 /

+0.69 (+6.06%)

EFTR eFfector Therapeutics
/

+

DLO DLocal
$10.74 /

-3.085 (-22.31%)

COST Costco
$501.79 /

+14.74 (+3.03%)

COHR Coherent
$36.59 /

+4.19 (+12.93%)

BKE The Buckle
$31.81 /

+0.55 (+1.76%)

BIG Big Lots
$6.11 /

-1.105 (-15.32%)

ADSK Autodesk
$196.48 /

-1.09 (-0.55%)

  • 23
    May
  • 06
    Jan
WDAY Workday
$217.97 /

+21.75 (+11.08%)

WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

TSLA Tesla
$192.63 /

+8.21 (+4.45%)

TLRY Tilray
$1.87 /

-0.49 (-20.81%)

TEVA Teva
$7.44 /

+0.105 (+1.43%)

PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

PARAA Paramount
$17.34 /

+1.1 (+6.77%)

PARA Paramount
$14.89 /

+0.805 (+5.72%)

NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

MU Micron
$73.83 /

+4.24 (+6.09%)

MRVL Marvell
$62.70 /

+13.25 (+26.79%)

JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

GPS Gap
$8.21 /

+0.79 (+10.65%)

FRCB First Republic Bank
/

+

F Ford
$12.07 /

+0.69 (+6.06%)

DLO DLocal
$10.74 /

-3.085 (-22.31%)

COST Costco
$501.79 /

+14.74 (+3.03%)

WDAY Workday
$217.97 /

+21.75 (+11.08%)

WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

TSLA Tesla
$192.63 /

+8.21 (+4.45%)

TLRY Tilray
$1.87 /

-0.49 (-20.81%)

TEVA Teva
$7.44 /

+0.105 (+1.43%)

PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

PARAA Paramount
$17.34 /

+1.1 (+6.77%)

PARA Paramount
$14.89 /

+0.805 (+5.72%)

NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

MU Micron
$73.83 /

+4.24 (+6.09%)

MRVL Marvell
$62.70 /

+13.25 (+26.79%)

MDB MongoDB
$289.57 /

+4.335 (+1.52%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

HIBB Hibbett
$39.77 /

-4.33 (-9.82%)

GPS Gap
$8.21 /

+0.79 (+10.65%)

GH Guardant Health
$28.25 /

+0.35 (+1.25%)

GERN Geron
$3.45 /

+0.305 (+9.70%)

F Ford
$12.07 /

+0.69 (+6.06%)

DLO DLocal
$10.74 /

-3.085 (-22.31%)

COST Costco
$501.79 /

+14.74 (+3.03%)

COHR Coherent
$36.59 /

+4.19 (+12.93%)

BKE The Buckle
$31.81 /

+0.55 (+1.76%)

BIG Big Lots
$6.11 /

-1.105 (-15.32%)

ADSK Autodesk
$196.48 /

-1.09 (-0.55%)

WDAY Workday
$217.97 /

+21.75 (+11.08%)

WBA Walgreens Boots Alliance
$29.79 /

-0.17 (-0.57%)

ULTA Ulta Beauty
$425.15 /

-60.5 (-12.46%)

TSLA Tesla
$192.63 /

+8.21 (+4.45%)

TLRY Tilray
$1.87 /

-0.49 (-20.81%)

TEVA Teva
$7.44 /

+0.105 (+1.43%)

PDD PDD Holdings
$70.51 /

+10.52 (+17.54%)

PARA Paramount
$14.89 /

+0.805 (+5.72%)

NVDA Nvidia
$386.53 /

+7.01 (+1.85%)

MU Micron
$73.83 /

+4.24 (+6.09%)

MRVL Marvell
$62.70 /

+13.25 (+26.79%)

MDB MongoDB
$289.57 /

+4.335 (+1.52%)

LLAP Terran Orbital
$1.18 /

-0.06 (-4.84%)

JPM JPMorgan
$136.91 /

+1.24 (+0.91%)

GPS Gap
$8.21 /

+0.79 (+10.65%)

GH Guardant Health
$28.25 /

+0.35 (+1.25%)

F Ford
$12.07 /

+0.69 (+6.06%)

DLO DLocal
$10.74 /

-3.085 (-22.31%)

COST Costco
$501.79 /

+14.74 (+3.03%)

BIG Big Lots
$6.11 /

-1.105 (-15.32%)

ADSK Autodesk
$196.48 /

-1.09 (-0.55%)

Thursday
Hot Stocks
Geron: Data support NDA submission for imetelstat on track for June 2023 » 17:17
05/25/23
05/25
17:17
05/25/23
17:17
GERN

Geron

$3.15 /

-0.005 (-0.16%)

Geron announced…

Geron announced acceptance of its IMerge Phase 3 abstract as an oral presentation at the upcoming 2023 American Society of Clinical Oncology ASCO Annual Meeting. This abstract describes statistically significant positive efficacy and safety data from the pivotal IMerge Phase 3 clinical trial evaluating the Company's first-in-class telomerase inhibitor, imetelstat, in lower risk myelodysplastic syndromes MDS . These data support the Company's planned New Drug Application NDA submission to the U.S. FDA which is on track for June 2023, to support a potential U.S. commercial launch of IMerge in lower risk MDS in the first half of 2024. "We believe that imetelstat has the potential to be practice-changing in lower risk MDS based on the unprecedented durability of transfusion independence, as well as broad activity across a range of disease subtypes in IMerge Phase 3," said Faye Feller, M.D., Executive Vice President, Chief Medical Officer of Geron. "We are thrilled that these data will be featured in an oral presentation at ASCO, where we will have a significant medical affairs presence to bring more awareness to the continuing unmet need in lower risk MDS and very much look forward to meaningful engagement with the medical community."

ShowHide Related Items >><<
GERN Geron
$3.15 /

-0.005 (-0.16%)

GERN Geron
$3.15 /

-0.005 (-0.16%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
GERN Geron
$3.15 /

-0.005 (-0.16%)

  • 06
    Jan
GERN Geron
$3.15 /

-0.005 (-0.16%)

Over a week ago
Hot Stocks
Geron to report updated durability, favorable PRO at EHA annual meeting » 10:03
05/11/23
05/11
10:03
05/11/23
10:03
GERN

Geron

$2.83 /

+0.01 (+0.36%)

Geron announced that five…

Geron announced that five abstracts related to imetelstat, a first-in-class telomerase inhibitor, have been accepted at the European Hematology Association Annual Meeting taking place from June 8-11, 2023 in Frankfurt, Germany and virtually. The three EHA abstracts on IMerge Phase 3 data expand upon and further confirm the differentiating qualities of imetelstat that can address current unmet needs for lower risk MDS patients compared to available treatments. In addition, abstracts submitted by Geron collaborators covering a translational analysis from a subset of IMerge Phase 2 patients and imetelstat MF pre-clinical data were accepted for oral and poster presentation, respectively. The company will report: Longer follow-up data for 1-year transfusion independence in IMerge Phase 3, which demonstrated statistically significant and clinically meaningful continuous, durable efficacy; Strong correlation of reduction in MDS-associated mutations with clinical benefits, including TI duration, provides compelling evidence for the potential of disease modification; Based on PRO data, imetelstat-treated patients were more likely to have sustained meaningful improvement in fatigue, as well as experience such improvement more quickly; Data support NDA submission which is on track for June 2023 to support potential U.S. commercial launch in first half of 2024.

ShowHide Related Items >><<
GERN Geron
$2.83 /

+0.01 (+0.36%)

GERN Geron
$2.83 /

+0.01 (+0.36%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
GERN Geron
$2.83 /

+0.01 (+0.36%)

  • 06
    Jan
GERN Geron
$2.83 /

+0.01 (+0.36%)

Hot Stocks
Geron sees FY23 expenses $200M-$210M » 08:13
05/11/23
05/11
08:13
05/11/23
08:13
GERN

Geron

$2.82 /

+0.01 (+0.36%)

The company said,…

The company said, "For fiscal year 2023, under generally accepted accounting principles (GAAP), the Company continues to expect total expenses in the range of approximately $210 million to $220 million, which includes non-cash items such as: stock-based compensation expense, amortization of debt discounts and issuance costs and depreciation and amortization. The Company expects non-GAAP total expenses for fiscal year 2023 to be in the range of approximately $200 million to $210 million. This guidance excludes estimated non-cash items such as: stock-based compensation expense, amortization of debt discounts and issuance costs, as well as depreciation and amortization. "

ShowHide Related Items >><<
GERN Geron
$2.82 /

+0.01 (+0.36%)

GERN Geron
$2.82 /

+0.01 (+0.36%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
GERN Geron
$2.82 /

+0.01 (+0.36%)

  • 06
    Jan
GERN Geron
$2.82 /

+0.01 (+0.36%)

Earnings
Geron reports Q1 EPS (7c), consensus (10c) » 08:12
05/11/23
05/11
08:12
05/11/23
08:12
GERN

Geron

$2.82 /

+0.01 (+0.36%)

Reports Q1 revenue…

Reports Q1 revenue $21,000, consensus $80,000. "We believe that imetelstat has a compelling commercial value proposition and is well-positioned to become a standard of care in lower risk MDS, based on unprecedented broad durability of transfusion independence in the IMerge Phase 3 trial and high unmet need in this patient population," said John A. Scarlett, chairman and CEO. "We are on track to submit a New Drug Application in the U.S. next month and are preparing for a potential U.S. commercial launch in the first half of 2024. Further, we are planning to submit a Marketing Authorization Application in the EU in the second half of 2023 and preparing for an EU commercial launch by the end of 2024."

ShowHide Related Items >><<
GERN Geron
$2.82 /

+0.01 (+0.36%)

GERN Geron
$2.82 /

+0.01 (+0.36%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
GERN Geron
$2.82 /

+0.01 (+0.36%)

  • 06
    Jan
GERN Geron
$2.82 /

+0.01 (+0.36%)

Hot Stocks
Marker Therapeutics appoints Monic Stuart as Chief Medical Officer » 07:35
05/08/23
05/08
07:35
05/08/23
07:35
MRKR

Marker Therapeutics

$1.42 /

-0.085 (-5.67%)

, GERN

Geron

$2.75 /

+0.06 (+2.23%)

Marker Therapeutics…

Marker Therapeutics (MRKR) announced the appointment of Monic Stuart, M.D., as its new Chief Medical Officer. Dr. Stuart brings more than 20 years of experience as a clinician-scientist and drug developer to Marker Therapeutics where she will be responsible for advancing the development of multi-tumor associated antigen-specific T cell product pipeline, including the ongoing MT-401 Phase 2 ARTEMIS clinical study and Phase 1 clinical study of MT-601. Dr. Stuart previously served as Vice President of Clinical Development at Geron Corporation (GERN).

ShowHide Related Items >><<
MRKR Marker Therapeutics
$1.42 /

-0.085 (-5.67%)

GERN Geron
$2.75 /

+0.06 (+2.23%)

MRKR Marker Therapeutics
$1.42 /

-0.085 (-5.67%)

05/27/22 Piper Sandler
Marker Therapeutics price target lowered to $1.50 from $3.50 at Piper Sandler
GERN Geron
$2.75 /

+0.06 (+2.23%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
MRKR Marker Therapeutics
$1.42 /

-0.085 (-5.67%)

GERN Geron
$2.75 /

+0.06 (+2.23%)

  • 06
    Jan
GERN Geron
$2.75 /

+0.06 (+2.23%)

Over a month ago
Hot Stocks
Geron to present data from IMerge Phase 3 trial at ASCO » 10:09
04/26/23
04/26
10:09
04/26/23
10:09
GERN

Geron

$2.39 /

-0.015 (-0.62%)

Geron Corporation…

Geron Corporation announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the company's first-in-class telomerase inhibitor, imetelstat, in lower risk myelodysplastic syndromes, was accepted for oral presentation at the 2023 American Society of Clinical Oncology Annual Meeting. The data in the ASCO abstract will be embargoed per ASCO guidelines until May 25, 2023 at 5 p.m. Eastern Time. ASCO is taking place in Chicago, IL from June 2-6, 2023.

ShowHide Related Items >><<
GERN Geron
$2.39 /

-0.015 (-0.62%)

GERN Geron
$2.39 /

-0.015 (-0.62%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
GERN Geron
$2.39 /

-0.015 (-0.62%)

  • 06
    Jan
GERN Geron
$2.39 /

-0.015 (-0.62%)

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:06
04/21/23
04/21
11:06
04/21/23
11:06
GMAB

Genmab

$40.90 /

+0.25 (+0.62%)

, ARGX

Argenx

$385.87 /

+5.72 (+1.50%)

, KURA

Kura Oncology

$10.84 /

+0.07 (+0.65%)

, IMGN

ImmunoGen

$4.21 /

+0.075 (+1.81%)

, GERN

Geron

$2.51 /

-0.01 (-0.40%)

, CDXS

Codexis

$4.11 /

-0.01 (-0.24%)

These names in the…

ShowHide Related Items >><<
KURA Kura Oncology
$10.84 /

+0.07 (+0.65%)

IMGN ImmunoGen
$4.21 /

+0.075 (+1.81%)

GMAB Genmab
$40.90 /

+0.25 (+0.62%)

GERN Geron
$2.51 /

-0.01 (-0.40%)

CDXS Codexis
$4.11 /

-0.01 (-0.24%)

ARGX Argenx
$385.87 /

+5.72 (+1.50%)

GMAB Genmab
$40.90 /

+0.25 (+0.62%)

03/09/23 JPMorgan
Genmab price target lowered to DKK 3,400 from DKK 3,600 at JPMorgan
03/02/23 H.C. Wainwright
Genmab price target lowered to $46 from $51 at H.C. Wainwright
02/23/23 Danske Bank
Genmab upgraded to Buy from Hold at Danske Bank
01/03/23 JPMorgan
Genmab price target raised to DKK 3,600 from DKK 3,450 at JPMorgan
ARGX Argenx
$385.87 /

+5.72 (+1.50%)

03/29/23 Stifel
Immunovant initiated with a Buy at Stifel
03/20/23 H.C. Wainwright
Argenx price target raised to $482 from $480 at H.C. Wainwright
03/14/23 Baird
Argenx upgraded to Outperform at Baird ahead of Phase 3 results in CIDP
KURA Kura Oncology
$10.84 /

+0.07 (+0.65%)

04/17/23 H.C. Wainwright
Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright
01/30/23 Stifel
Kura Oncology initiated with a Buy at Stifel
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
07/12/22 Cantor Fitzgerald
Kura Oncology initiated with an Overweight at Cantor Fitzgerald
IMGN ImmunoGen
$4.21 /

+0.075 (+1.81%)

03/20/23 Wells Fargo
Sutro transferred with Equal Weight from Overweight at Wells Fargo
03/01/23 Guggenheim
Immunogen confident in early Elahere launch, says Guggenheim
12/30/22 H.C. Wainwright
ImmunoGen price target lowered to $15 from $20 at H.C. Wainwright
12/28/22 William Blair
NCCN guidelines upside surprise for ImmunoGen, says William Blair
GERN Geron
$2.51 /

-0.01 (-0.40%)

03/27/23 Goldman Sachs
Geron initiated with a Neutral at Goldman Sachs
01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
CDXS Codexis
$4.11 /

-0.01 (-0.24%)

04/17/23 Piper Sandler
Codexis price target lowered to $14 from $21 at Piper Sandler
02/27/23 H.C. Wainwright
Codexis price target lowered to $9 from $15 at H.C. Wainwright
01/19/23 Piper Sandler
Codexis price target raised to $23 from $22 at Piper Sandler
11/07/22 H.C. Wainwright
Codexis price target lowered to $15 from $25 at H.C. Wainwright
KURA Kura Oncology
$10.84 /

+0.07 (+0.65%)

IMGN ImmunoGen
$4.21 /

+0.075 (+1.81%)

GERN Geron
$2.51 /

-0.01 (-0.40%)

CDXS Codexis
$4.11 /

-0.01 (-0.24%)

ARGX Argenx
$385.87 /

+5.72 (+1.50%)

  • 06
    Jan
IMGN ImmunoGen
$4.21 /

+0.075 (+1.81%)

GMAB Genmab
$40.90 /

+0.25 (+0.62%)

GERN Geron
$2.51 /

-0.01 (-0.40%)

CDXS Codexis
$4.11 /

-0.01 (-0.24%)

ARGX Argenx
$385.87 /

+5.72 (+1.50%)

IMGN ImmunoGen
$4.21 /

+0.075 (+1.81%)

Initiation
Geron initiated with a Neutral at Goldman Sachs » 16:39
03/27/23
03/27
16:39
03/27/23
16:39
GERN

Geron

$2.35 /

+0.015 (+0.64%)

Goldman Sachs initiated…

Goldman Sachs initiated coverage of Geron with a Neutral rating and $3 price target. The analyst noted that Geron will submit for approval of imetelstat in LR-MDS in both the US/Europe in 2023, and assumes "a high likelihood of approval," but sees "limited potential discovery value for the agent over 2023 as the agent undergoes regulatory review." Goldman Sachs estimates the unadjusted global peak sales for imetelstat of $1.0B.

ShowHide Related Items >><<
GERN Geron
$2.35 /

+0.015 (+0.64%)

GERN Geron
$2.35 /

+0.015 (+0.64%)

01/09/23 B. Riley
Geron price target raised to $5 from $4 at B. Riley
01/04/23 Wedbush
Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
10/28/22 Wedbush
Wedbush starts Geron with Outperform, $5 price target
10/27/22 Wedbush
Geron initiated with an Outperform at Wedbush
GERN Geron
$2.35 /

+0.015 (+0.64%)

  • 06
    Jan
  • 30
    Mar
GERN Geron
$2.35 /

+0.015 (+0.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.